Perspective Therapeutics (CATX) Other Accumulated Expenses (2011 - 2023)
Perspective Therapeutics (CATX) posted Other Accumulated Expenses of $480000.0 for Q4 2023, up 1900.0% sequentially from $24000.0 in Q3 2023, and down 15.94% YoY from $571000.0 in Q4 2022.
Perspective Therapeutics (CATX) Other Accumulated Expenses (2011 - 2023) Analysis & Trends
Perspective Therapeutics has reported Other Accumulated Expenses for 13 years, with the latest figure at $480000.0 in Q4 2023.
- Quarterly Other Accumulated Expenses fell 15.94% year-over-year to $480000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $480000.0 (down 15.94% YoY) and the FY2023 annual result came in at $480000.0, down 15.94% from the prior year.
- Other Accumulated Expenses grew to $480000.0 in Q4 2023 per CATX's latest filing, from $24000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $571000.0 in Q4 2022 and troughed at $15000.0 in Q1 2023.
- A 5-year average of $127300.0 and a median of $96500.0 in 2020 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses surged 454.37% in 2022, then tumbled 84.04% in 2023.
- Over 5 years, Other Accumulated Expenses stood at $89000.0 in 2019, then grew by 13.48% to $101000.0 in 2020, then gained by 1.98% to $103000.0 in 2021, then soared by 454.37% to $571000.0 in 2022, then dropped by 15.94% to $480000.0 in 2023.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $480000.0, $24000.0, and $20000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 480,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 571,000.00 |
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Sep 30, 2021 | 102,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 101,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Mar 31, 2020 | 87,000.00 |
| Dec 31, 2019 | 89,000.00 |
| Sep 30, 2019 | 83,000.00 |
| Jun 30, 2019 | 74,000.00 |
| Mar 31, 2019 | 65,000.00 |